Diadema Partners’s Arvinas ARVN Stock Holding History

Diadema Partners’s Portfolio ARVN Stock Details ARVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,300	Closed	-$44.1K	–	111
2024 Q4	$44.1K	Buy	+2,300	New	+$55.9K	0.02%	98

Other funds holding ARVN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Diadema Partners's ARVN Position: Q3 2025 in Review

Diadema Partners sold out of Arvinas (ARVN) in Q3 2025, closing a stake of 96,455 shares — an estimated $710K sold.

Diadema Partners first reported a position in ARVN in Q2 2025 and held it in 1 quarter. The position peaked at $710K in Q2 2025. 211 funds tracked by Wall St. Rank hold ARVN as of Q3 2025.

Diadema Partners reported no remaining Arvinas position as of Q3 2025 after selling out during the quarter.
Diadema Partners sold 96,455 Arvinas shares in Q3 2025, an estimated $710K.
Diadema Partners first reported a position in Arvinas in Q2 2025 and held it in 1 quarter.
Diadema Partners's Arvinas position peaked at $710K in Q2 2025.
211 funds tracked by Wall St. Rank held Arvinas as of Q3 2025.

Based on Diadema Partners's 13F filing for Q3 2025, filed 14 Nov 2025.